Company Overview of Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic liver failure and chronic liver failure, as well as for the patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection. The company was founded in 2005 and is headquartered in San Diego, California.
4365 Executive Drive
San Diego, CA 92121
Founded in 2005
Key Executives for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc. Key Developments
Similar Private Companies By Industry
|Nova BioGenetics Inc.||United States|
|Skinovation Pharmaceutical Inc.||United States|
|Sigma-Aldrich RTC, Inc.||United States|
|Appian International Research, Inc.||United States|
|NBTY Manufacturing, LLC||United States|
Recent Private Companies Transactions
May 30, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Summit, NJ | DiversantPosted: Jul 03
- Fort Lauderdale, FL | Broward HealthPosted: Dec 16
- Brown Deer, WI | Kelly Scientific ResourcesPosted: Dec 13
- Spring House, PA | Johnson & JohnsonPosted: Dec 17
Sponsored Financial Commentaries
To contact Conatus Pharmaceuticals Inc., please visit www.conatuspharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.